Impact of pediatric vaccination with pneumococcal conjugate vaccine on the risk of bacteremic pneumococcal pneumonia in adults

Vaccine

Volumn 24, Issue 4, 2006, Pages 468-475

  Metlay, Joshua P ^a,b   Fishman, Neil O ^b   Joffe, Marshall ^b   Edelstein, Paul H ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Bacteremia; Herd immunity; Pneumococcal infections; Pneumococcal vaccines

Indexed keywords

PNEUMOCOCCUS VACCINE;

ADULT; AGED; CASE CONTROL STUDY; CONFERENCE PAPER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG CONJUGATION; FEMALE; HOME; HOSPITAL; HUMAN; INTERVIEW; LABORATORY; LOBAR PNEUMONIA; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTECTION; SEROTYPE; TELEPHONE; UNITED STATES; VACCINATION;

ADULT; BACTEREMIA; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; HUMANS; INFANT; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STREPTOCOCCUS PNEUMONIAE; VACCINES, CONJUGATE;

EID: 29244451029     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.07.095     Document Type: Conference Paper

References (18)

1. American Academy of Pediatrics. Committee on Infectious Diseases. Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics 2000;106 (2 Pt 1):362-6.
2. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2000;49 (RR-9):1-35.
3. S.K. Obaro, R.A. Adegbola, W.A. Banya, and B.M. Greenwood Carriage of pneumococci after pneumococcal vaccination Lancet 348 9022 1996 271 272
4. R. Dagan, R. Melamed, M. Muallem, L. Piglansky, D. Greenberg, and O. Abramson Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine J Infect Dis 174 6 1996 1271 1278
5. J.P. Nuorti, J.C. Butler, M.M. Farley, L.H. Harrison, A. McGeer, and M.S. Kolczak Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team N Engl J Med 342 10 2000 681 689
6. K.L. O'Brien, and R. Dagan The potential indirect effect of conjugate pneumococcal vaccines Vaccine 21 17/18 2003 1815 1825
7. C.G. Whitney, M.M. Farley, J. Hadler, L.H. Harrison, N.M. Bennett, and R. Lynfield Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine N Engl J Med 348 18 2003 1737 1746
8. B. Flannery, S. Schrag, N.M. Bennett, R. Lynfield, L.H. Harrison, and A. Reingold Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections Jama 291 18 2004 2197 2203
9. S. Black, H. Shinefield, R. Baxter, R. Austrian, L. Bracken, and J. Hansen Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente Pediatr Infect Dis J 23 6 2004 485 489
10. H.B. Konradsen, and H. Nokleby The conjugate vaccine and invasive pneumococcal disease N Engl J Med 349 7 2003 714 716 author reply 714-716
11. C. Czaja, L. Crossette, and J.P. Metlay Accuracy of adult reported pneumococcal vaccination status of children Ann Epidemiol 15 4 2005 253 256
12. E. Koneman, S. Allen, W. Janda, P. Schreckenberger, and W. Winn Jr. Color atlas and textbook of diagnostic microbiology 5th ed. 1997 Lippincott-Raven Philadelphia
13. R. Austrian The quellung reaction, a neglected microbiologic technique Mt Sinai J Med 43 6 1976 699 709
14. U.B. Sorensen Typing of pneumococci by using 12 pooled antisera J Clin Microbiol 31 8 1993 2097 2100
15. Pneumotest manual. 2001. Statens Serum Institut: Copenhagen.
16. D.R. Feikin, and K.P. Klugman Historical changes in pneumococcal serogroup distribution: implications for the era of pneumococcal conjugate vaccines Clin Infect Dis 35 5 2002 547 555
17. N. French, J. Nakiyingi, L.M. Carpenter, E. Lugada, C. Watera, and K. Moi 23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial Lancet 355 9221 2000 2106 2111
18. L.A. Jackson, K.M. Neuzil, O. Yu, P. Benson, W.E. Barlow, and A.L. Adams Effectiveness of pneumococcal polysaccharide vaccine in older adults N Engl J Med 348 18 2003 1747 1755